PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 23, 2024European Journal of Clinical Microbiology & Infectious Diseases15 citationsOpen Access

In vitro activity of cefiderocol against carbapenem-resistant Acinetobacter baumannii carrying various β-lactamase encoding genes

View Full Paper
AGAylin Üsküdar GüçlüSDSalih DanyildizHMHasan Cenk Mirza

Key Points

Key points are not available for this paper at this time.

Abstract

This study aimed to determine the in vitro efficacy of cefiderocol in carbapenem-resistant Acinetobacter baumannii (CRAB) isolates and evaluate the disk-diffusion (DD) method as an alternative method to broth-microdilution (BMD).

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Güçlü et al. (2024) studied this question.

synapsesocial.com/papers/68e6de7cb6db64358765aa36https://doi.org/10.1007/s10096-024-04831-w
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1In Vitro Activity of Cefiderocol, Eravacycline, and Imipenem–Relebactam Against Multidrug-Resistant Acinetobacter baumannii Clinical Isolates2026
  2. 2In vitro evaluation of using ceftazidime/avibactam against carbapenem-resistant Acinetobacter baumannii2024 · 3 citations
  3. 3<i>In vitro</i> activity of cefiderocol against nosocomial <i>Acinetobacter baumannii</i>2025 · 1 citations
  4. 4<i>In vitro</i> activity of cefiderocol and sulbactam–durlobactam against carbapenem-resistant <i>Acinetobacter baumannii</i> clinical isolates collected between 2019 and 20242025
  5. 5In vitro activity of cefiderocol and sulbactam-durlobactam against clinical-isolated carbapenem-resistant Acinetobacter baumannii from China2026